Ethnopharmacological relevance: Sri Lanka is known to have very diverse flora. Many of these species are used for plant-based remedies, which form the integral part of two Sri Lankan systems of traditional medicine, Ayurveda and Deshiya Chikitsa. Despite their widespread use, only a limited number of studies have probed into the scientific evidence for bioactivity of these medicinal plants. Such studies rarely progress to the identification of bioactive natural products. Aim of the study: The primary aim was to develop a bioactivity screening method and apply it to 50 Sri Lankan medicinal plants where antimicrobial properties could be relevant for its traditional use. The subsequent aim was the progression into defining and characterising potent isolates within targeted compound classes from such plants, i.e. Derris scandens and its antimicrobial flavonoids. Material and methods: The plant collection comprised 24 species of Fabaceae, 15 Rubiaceae, 7 Solanaceae and 4 Cucurbitaceae plants. These 50 species were collected based on their ethnopharmacological importance and use in Sri Lankan traditional medicine. Crude extracts from each species were initially subjected to radial disc diffusion and microdilution assays. Subsequently, aqueous extracts of all plants were microfractionated in deep well plates using reversed-phase HPLC. Fractions were tested for antibacterial and cytotoxic activities and masses of target bioactive compounds were identified using mass spectrometry. Bioactive compounds with the masses identified through microfractions were isolated from Derris scandens using reversed-phase HPLC. The isolated pure compounds were characterised using LC-MS and NMR. Results: Crude aqueous extracts from 19 species showed activity against Gram-positive bacteria (Staphylococcus aureus and Bacillus cereus) in the radial disc diffusion assay. Crude aqueous extracts from 34 plant species and organic extracts from 46 plant species were active against S. aureus (≤4 mg mL -1 ) in the microdilution assay. Microfractionation demonstrated antibacterial activity for 19 plants and cytotoxicity for 6 plants. Furthermore, target bioactive compounds and their molecular ions were identified during microfractionation. Dalpanitin and vicenin-3, two of the flavonoids isolated from Derris scandens gave MICs of 23 μg mL -1 against S. aureus. Dalpanitin also exhibited relevant MICs on Gram-negative bacteria (94 μg mL -1 against Escherichia coli and Pseudomonas aeruginosa). Conclusion: The microfractionation protocol developed in this study enabled time-efficient screening of many plants species, using a small quantity of sample material. In addition, microfractionation served as a guiding tool for identifying individual antimicrobial compounds. Through this process, flavonoids were isolated from Derris scandens, out of which dalpanitin and vicenin-3 showed activity in the low micromolar range. The high hit rate https://doi.
Introduction
Sri Lanka is considered a global biodiversity hotspot due to its diverse and lush ecosystems (Dharmadasa et al., 2016; Myers et al., 2000) . Around 30% of Sri Lanka is covered by forest and the island is home to 3154 angiosperm species, one quarter of which are endemic (Wijesundara et al., 2012) . The usage of plants has penetrated much of the Sri Lankan culture, particularly in traditional health care. The traditional medical system in Sri Lanka is mainly composed of four different practices: Siddha, Unani, Ayurveda, and Deshiya Chikitsa (Weragoda, 1980) . The latter two mainly rely on plant and herbal preparations, used either as single plants or extracts, or complex mixtures of several species, for the treatment of diseases. The remedies in Ayurvedic medical manuscripts are the fruits of over 3000 years of empirical experience handed down from generation to generation (Liyanaratne, 1991) and as such represent a valuable pre-screening source available in traditional medicine.
Medicinal plants have been a valuable source of therapeutic agents, and still many of today's drugs are plant-derived natural products or their derivatives (Chalovich and Eisenberg, 2005; Newman and Cragg, 2016) . Plants used in traditional medicine for over centuries by humans can be perceived to have undergone clinical testing for safety and efficacy parameters, albeit without current scientific standards and scrutiny. Thus, compounds derived from these plants presumably have greater potential to succeed in toxicology screening compared to a de novo synthetic chemical compound. However, among antibacterial agents in conventional clinical use, there is a noteworthy absence of plant-derived compounds so far, despite the long and widespread traditional use of plant-based remedies.
Although medicinal plants have been used as remedies for human diseases for centuries, most Sri Lankan medicinal plants have not been chemically studied (Rathnayake and Weerasinghe, 2018) . Given that there are dynamic changes in plant metabolite profile based on geographical location and environmental condition (Pavarini et al., 2012; Sampaio et al., 2016) , these plants are an untapped resource of natural products awaiting discovery. Most studies investigating bioactive properties of Sri Lankan medicinal plants rarely progress to studies at molecular level due to limited scientific instrumentation for further chemical characterisation and inadequate facilities to conduct bioassays locally. Typically, scientific efforts are limited to reporting bioactivity of crude plants extracts or decoctions.
One such plant species is Derris scandens, locally called ʽkala walʼ. It grows throughout Asia and has been used in Ayurvedic, Thai and Chinese herbal medicine to treat a variety of pain-related conditions, including muscle pain, joint pain, arthritis and headaches. The stem part is used as a diuretic, expectorant, anti-tussive and anti-dysentery agent and for muscle pains (Hussain et al., 2015) . It is also used for the treatment of osteoarthritis and inflammation (Kuljittichanok et al., 2018; Laupattarakasem et al., 2004) . Notably, it is used by indigenous people in Sri Lanka commonly known as 'veddas' for wound healing and in a traditional method of fishing to immobilise the fish to facilitate their capture (Chandraratne, 2016) . The ethanol extract of the plant has been shown to have anti-metastatic activity in cholangiocarcinoma and hepatoma cell lines (Kuljittichanok et al., 2018) .
In the present study, we adapted a microfractionation protocol, coupled with mass spectrometry (MS) and bioactivity screening, to enable rapid screening of a large number of medicinal plants traditionally used in Sri Lanka. This method is a targeted and streamlined approach, applicable for the isolation of many natural product classes. As shown in Scheme 1, 50 plant species from four families (Fabaceae, Cucurbitaceae, Rubiaceae and Solanaceae) were selected based on traditional usage by Ayurvedic practitioners and subjected to the microfractionation protocol followed by antibacterial and cytotoxic activity screening. By following the targeted masses identified from the initial screening, four known flavonoids were isolated from Derris scandens and their structures were then identified by comparison of nuclear magnetic resonance (NMR) spectroscopic data to literature values. Sakharkar and Chauhan (2017) 12 Crotalaria retusa L. Kaha andanahiriya UOC/NPSD/060 Diarrhoea and skin diseases. -Neto et al. (2010) 13 Crotalaria verrucosa L.
Genotoxicity

Silva
Nil andanahiriya UOC/NPSD/061 Rashes, diseases of the mouth, cough, asthma.
Antibacterial, cytotoxicity Nowrin (2016) 14 Datura metel L. The information on G. repens, G. speciosa, H. auricularia, K. zeylanica, M. parvifolia, S. macrocarpon and S. nigrum was obtained through discussions with local traditional medicine practitioners.
Materials and methods
Plant material
Plant materials were collected from Bandaranayake Memorial Ayurvedic Research Institute, Mahargama and private lands (in Kamburupitiya, Mirigama and Pussellawa). Different plant parts (roots, leaves, stem bark, root bark) of 50 plants were collected based on their traditional Ayurvedic usage (Table 1 ). The plant species were initially identified by a field guide. Later, the identity of the plant specimens was confirmed by N.P.T. Gunawardena at the National Herbarium of the Royal Botanical Garden, Peradeniya. A voucher specimen (No. UOC/ NPSD/062) of D. scandens and the other plants studied for antibacterial activity and cytotoxicity were deposited in the herbarium of Department of Plant Sciences, University of Colombo, Sri Lanka.
Small scale extraction
Plant parts (roots, leaves, stem bark, root bark) were separately washed with water, air dried for 3 to 5 days at room temperature (30°C) and separately pulverised using a domestic grinder. A portion (150 mg) from each plant part was extracted using dichloromethane (CH 2 Cl 2 ) and methanol (MeOH) (1:1, v/v, 100 mL) using an ultra-sonic bath at room temperature and filtered under reduced pressure. Filtrates of repeated extractions were combined and the organic phase was concentrated under reduced pressure at 40°C using a rotary evaporator. The dried crude extracts obtained were further dried using nitrogen gas (N 2 ) and the dry weights were recorded.
Microfractionation by HPLC
The dried crude extract (20 mg) was re-suspended in 10 mL of MeOH and CH 2 Cl 2 (1:1, v/v) and partitioned using 20 mL of distilled water. The aqueous and organic layers were collected separately and MeOH was removed by rotary evaporation. Freeze-dried aqueous extract (2 mg) was dissolved in 1 mL of 5% acetonitrile (CH 3 CN) and fractionated by Shimadzu LC-10 system equipped with a SPD-M10AVP Photodiode Array Detector (PDA). A Phenomenex Jupiter C 18 (250 × 4.6 mm, 5 μm) column with a gradient from H 2 O/0.05% trifluoroacetic acid (TFA) (95%)/CH 3 CN/0.05% TFA (5%) to H 2 O/0.05% TFA (5%)/CH 3 CN/0.05% TFA (95%) over 45 min at a flow rate of 1 mL min -1 was employed. Each 1 mL of 45 fractions were collected into a 96 deep well plate (VWR, Sweden). 100 μL from each well was transferred into a 96-well U-bottom plate (Greiner Bio-one, USA) for antibacterial activity screening and a 96-well V-bottom plate (Thermo Scientific, Denmark) for lymphoma cell (U-937GTB) toxicity screening separately. The plates were dried in a centrifugal evaporator (Savant Speed Vac plus SC110A) and subjected to the respective assays.
Identification of target masses for isolation
Active fractions from antimicrobial assays were subjected to liquid chromatography-ultra violet diode array detector-mass spectrometry (LC-UV-MS) analysis to determine the corresponding molecular ions present in each well. Each active fraction in the deep well plate was diluted to a final concentration of 5% CH 3 CN and analysed by Shimadzu LC-10 system equipped with an PDA detector (Kinetex C 18 , 100 × 4.60 mm 2.6 μm, 100 Å) at a flow rate of 1 mL min -1 . A gradient from H 2 O/0.1% formic acid (FA) (95%)/CH 3 CN/0.1% FA (5%) to H 2 O/ 0.1% FA (40%)/CH 3 CN/0.1% FA (60%) over 12 min was employed and UV data were collected between 190 nm and 600 nm. Mass spectrometric analysis of fractions was performed on a LCQ mass spectrometer (Finnigan LCQ, San Jose, CA, USA), equipped with an electrospray ionization (ESI) source (capillary temperature of 250°C, capillary voltage of 5 kV, and sheath gas flow of 80 arbitrary units). Dominant molecular ions in the active fractions were identified in both positive and negative ion modes for 100-2000 m/z range.
Extraction and isolation
D. scandens leaf powder (500 g) was exhaustively extracted in 2 L of hexane with sonication for 30 min at room temperature. The extraction was repeated twice and the organic phase from the combined filtrates was evaporated to dryness under reduced pressure at 40°C using a rotary evaporator. The crude hexane extract obtained was further dried using N 2 gas and the dry weight was recorded. Remaining plant material from the hexane extraction was dried and sequentially extracted with CH 2 Cl 2 (2 L), ethyl acetate (EtOAc) (2 L) and MeOH (2 L) following the same above procedure.
D. scandens leaf EtOAc extract was partitioned with water and the freeze-dried aqueous crude extract (50 mg) was dissolved in 10 mL of 5% CH 3 CN for fractionation on preparative reversed-phase high performance liquid chromatography (RP-HPLC) (Waters 600 Controller). A gradient from H 2 O/0.05% TFA (95%)/CH 3 CN/0.05% TFA (5%) to H 2 O/0.05% TFA (20%)/CH 3 CN/0.05% TFA (80%) over 75 min was employed to collect 100 fractions of 8 mL each using a fraction collector (Pharmacia LKB FRAC 100). The fractions containing the bioactive compounds and molecular ions identified from microfractionation protocol were combined, freeze-dried and further purified by semipreparative RP-HPLC (Jupiter C 18 , 250 × 10.00 mm, 5 μm, 300 Å), using a Waters 600 Controller system at a flow rate of 4 mL min −1 . LC-UV-MS was performed on the fractions and selected fractions were further purified using LH-20. Freeze-dried fractions were then dissolved in 20 mL of MeOH and loaded to Sephadex® LH-20 column (35 cm × 1.5 cm), and eluted with MeOH (500 mL) with a flow rate of 1.8 mL min -1 to yield fractions of approximately 10 mL.
Analytical RP-HPLC was performed on the isolated compounds to determine the purity on a Shimadzu LC-10 system equipped with a PDA Detector (Kinetex C 18 , 100 × 4.60 mm 2.6 μm, 100 Å) using a gradient from H 2 O/0.1% FA (95%)/CH 3 CN/0.1% FA (5%) to H 2 O/0.1% FA (40%)/CH 3 CN/0.1% FA (60%) over 18 min.
(+)HRESIMS of the pure compounds (0.1 mg mL -1 ) were analysed on nano Acquity UPLC-QTOF mass spectrometer (Waters, Milford, MA) for the mass of range 100-1000 Da using a nano LC Waters C 18 column (150 × 0.075 mm column, 5 μm) with a 0.30 μL min -1 flow rate. Mass spectrometer was calibrated with standard mass to ensure that the mass error was below five ppm. The mass spectrum was obtained in positive ion mode and data was processed through MassLynx V4.1 software.
NMR was performed to determine the structures of the pure compounds; NMR spectra for 1D 1 H and 13 C, 2D heteronuclear single quantum correlation (HSQC), 2D heteronuclear multiple bond correlation (HMBC) and 2D correlation spectroscopy (COSY) experiments were recorded at 25°C on a 600 MHz (Bruker) NMR spectrophotometer.
Biological assays 2.6.1. Agar disc diffusion assay for crude extracts
Antibacterial activity of the crude extracts was evaluated against S. aureus (ATCC 25928), B. cereus (ATCC 11778), P. aeruginosa (ATCC 9027) and E. coli (ATCC 35218). The bacterial cell suspensions were prepared according to the following procedure. The bacterial culture was streaked on Mueller Hinton (MH) agar medium and incubated overnight at 30°C. A small inoculum of overnight grown culture was taken with a sterile loop and dissolved in sterile saline water (0.9% NaCl, Sigma Aldrich, Korea). The cell suspension was ajdusted to a density of 1 × 10 8 cfu/mL using 0.5 McFarland standards. Each cell suspension (200 μL) was distributed evenly on the surface of dried Mueller Hinton Agar dishes or plates (Hardy, USA; 38.0 g in 1000 mL of distilled water). A small portion of the dried crude extract was dissolved in MeOH and CH 2 Cl 2 (1:1, v/v) to reach a final concentration of 20 mg mL -1 . 20 μL of the sample was delivered onto a sterile blank disc (Whatman grade A filter paper discs of 6 mm diameter) to obtain 400 Table 2 Antimicrobial activity of crude plant extracts (aqueous and organic) with the methods of agar disc diffusion assay, two-step microdilution assay (MIC on S. aureus), and fluorometric microculture cytotoxicity assay (FMCA on lymphoma cell line). Active fractions (identified as elution time) obtained from microfractionation protocol were tested against S. aureus and human lymphoma cells. These plants displayed MIC ≤0.1 mg mL-1 for aqueous layer. e These plants displayed MIC ≤0.1 mg mL −1 for organic layer. Zone of inhibition for the positive control (gentamycin, 20 μg/disc); S. aureus-23 ± 2 mm, B.
cereus-25 ± 2 mm. S. Mohotti, et al. Journal of Ethnopharmacology 246 (2020) 112158 μg/disc. A MeOH and CH 2 Cl 2 mixture (1:1, v/v, 20 μL) was used as the negative control and gentamycin (20 μg/disc) was used as the positive control.
Microdilution assay on bacteria and C. albicans
A two-step microdilution assay (Strömstedt et al., 2017) was used in the screening process to enable the detection of antimicrobial compounds sensitive to inhibition by rich growth media. This protocol has the added benefit of enhancing solubility of the extract, but should otherwise result in similar activity readings as the standard broth microdilution assay. The freeze-dried aqueous and organic fractions from small-scale extractions were subjected to minimum inhibitory concentration (MIC) determination against S. aureus (ATCC 29213). The crude extracts were assayed with a 2-fold serial dilution starting at 4 mg mL -1 , with the organic crude extract being pre-dissolved in 10% DMSO aq (16 mg mL -1 ). The prepared microfractionation microplates, containing fractionated and dried aqueous extract, as well as the purified compounds were tested by the same method. In short, the samples and microbes were co-incubated for 5 h in Tris buffer, after which 5 μL of concentrated (20%) tryptic soy broth was added (1% final concentration) followed by a further 9 h of incubation. Pure flavonoids isolated from D. scandens were subjected to microdilution assay against S. aureus (ATCC 29213), P. aeruginosa (ATCC 27853), E. coli (ATCC 25922) and C. albicans (ATCC 90028). Concentrations that exhibited total inhibition on visual inspection were defined as MICs and presented as medians from triplicate experiments.
Lymphoma cell toxicity assay
Cell toxicity of fractions from microfractionation were evaluated using the fluorometric microculture cytotoxicity assay (FMCA) (Lindhagen et al., 2008) , which is based on monitoring of fluorescence arising from fluorescein that is produced as a result of fluorescein diacetate (FDA) hydrolysis by cells with intact cell membranes. The histiocytic human lymphoma cell line U-937 GTB (Sundström and Nilsson, 1976) suspended in growth medium was dispensed into the extract-containing microtiter plates. Each well was seeded with 200 μL of cell suspension, containing approximately 20,000 cells, to give a total volume of 200 μL per well. The plates were then incubated for 72 h at 37°C in 5% CO 2 atmosphere. The plates were then centrifuged at 1000 rpm for 5 min at 37°C, the medium was removed by aspiration, Fig. 1. (A) HPLC-UV chromatogram (detected at 254 nm) of the crude aqueous extract of D. scandens with 2 mg sample loaded on to the column. Compounds isolated from the peak indicated by dashed line showed 100% of inhibition against S. aureus in the microfractions. (B) HPLC trace at 254 nm and mass profile (M + H) + of dalpanitin, rutin, vicenin-2 and vicenin-3. and the cells were washed with phosphate buffered saline (PBS) [80.0 mg of NaCl (Himedia, USA), 2.0 mg of KCl (Sigma), 14.4 mg of Na 2 HPO 4 (Sigma) and 2.4 mg of KH 2 PO 4 in 10.0 mL of distilled water]. FDA (10 mg FDA dissolved in 1 mL 100% DMSO, w/v) was added to preheated (37°C) Q2-buffer (40 mL of 125 mM NaCl, 10 mL of 25 mM Hepes added up to 400 mL with MQ-H 2 O, pH 7.4). A portion of this solution (100 μL) was then added to each well and incubated for 40 min at 37°C. Fluorescence at 538 nm in each well was measured (Thermoscientific Varioskan Flash) with excitation at 485 nm. The fluorescence in each well is proportional to the number of living cells and the cytotoxic activity is thus inversely proportional to fluorescence intensity. The activity of the microfractionated extracts and the pure compounds isolated from D. scandens is reported in terms of survival index (SI). It is defined as fluorescence in the experimental wells, expressed as a percentage of the control wells after the fluorescence of the blank wells is subtracted.
Results and discussion
Plant collection
The plant collection comprised 24 species from the Fabaceae, 4 Cucurbitaceae, 15 Rubiaceae and 7 Solanaceae. All species were collected based on their ethnopharmacological importance and use in Sri Lankan traditional medicine and practiced by local people. Information was gathered by interviewing traditional Ayurvedic practioners and from local Ayurvedic books. A summary of the traditional uses for these plants (Institute of Ayurveda, 2017) is listed in Table 1 .
Screening of crude extracts for antibacterial activity
Agar disc diffusion assay
The aqueous component derived from the MeOH/CH 2 Cl 2 (1:1 v/v) crude extracts was first subjected to an agar disc diffusion assay to identify the presence of potential antibacterial compounds. The inhibitory activity on bacteria was quantified by the diameter of the inhibition zone. Nineteen of the 50 species collected showed activity against Gram-positive bacteria (S. aureus and B. cereus) . None of the crude extracts showed activity against the Gram-negative bacteria, P. aeruginosa and E. coli (Table 2) . Among the tested plants, Withania somnifera (common local name: Amukkara), Datura metel (Attana), Spermacoce hispida (Hin Getakola) and Cassia fistula (Ehela) showed an inhibition zone of 12-13 mm diameter at 400 μg/disc against B. cereus. Geophila repens (Koturu bedde), S. hispida, D. metel, W. somnifera and D. scandens (Kala wal) showed an inhibition zone of 10-12 mm diameter at 400 μg/disc against S. aureus.
Microdilution assay
The crude extracts (aqueous and organic extracts) were tested against S. aureus as this strain was identified as frequently susceptible in the radial diffusion assay. Aqueous crude extracts from 34 plant species (68% of plants screened) were active against S. aureus (≤4 mg mL -1 ) ( Table 2 ). The highest antibacterial activity was recorded for W. somnifera, Wendlandia biscuspidata (Ravana idala) and C. fistula (MIC = 0.06 mg mL -1 ). In addition, Morinda umbellata (Kiriwel) and D. scandens also showed high antibacterial activity (MIC (≤0.1 mg mL -1 ). Organic extracts from 46 plant species (92% of the total) showed activity against S. aureus (≤4 mg mL -1 ). Notably, D. metel showed the highest antibacterial activity (MIC = 0.03 mg mL -1 ). Low MIC values (≤0.06 mg mL -1 ) for the organic extracts were also recorded for several plants. These were Solanum virginianum (Katuwel batu), Solanum melongena (Elabatu), W. somnifera, Paederia foetida (Apasu madu), Oldenlandia herbacea (Wal kothamalli), Adenanthera pavonina (Madatiya), Tamarindus indica (Siyambala) and Crotalaria retusa (Kaha andanahiriya). Fractions with antibacterial activity showed a pattern of activity: consecutive sets of wells showed gradual increase in activity to reach a climax after which a gradual decrease in activity was observed. The width of this pattern was an indication of the amount present in the extract of the active compound and suggested that well contents could be further diluted to identify the most potent target masses.
Although only 19 plant species gave activity against S. aureus in the agar disc diffusion assay, the two-step microdilution assay identified 34 and 46 plant species that contained antibacterial aqueous and organic fractions, respectively. The two methods present distinct conditions for the compounds affecting diffusion, scavenging and solubility, all of which may mask activity in the disc diffusion assay (Ge et al., 1999; Strömstedt et al., 2014) . The two-step microdilution assay monitors activity on both growing and non-growing bacteria and offers more precise estimates of potency. It also maximises solubility by avoiding partial saturation of the medium by broth components and by the option to use DMSO in order to enhance solubility of more hydrophobic compounds. This makes the microdilution assay more advantageous for the identification of cationic and less-polar bioactive compounds, compared to the agar disc diffusion method.
Screening of microfractionated aqueous extracts for antibacterial and cytotoxic activities
The microfractionation protocol was based on RP-HPLC combined with PDA and mass detection. The crude extracts from 50 plants were subjected to solvent-solvent partition separately to yield aqueous and organic extracts for each plant. Aqueous crude plant extract (2 mg) from each plant was fractionated into 45 fractions (1 mL x 45) in a deep well plate using RP-HPLC. 100 μL from each well was transferred into a 96-well plate and the contents in each well were tested by microdilution assay and by FMCA. The results from the microfractionation protocol are shown in Table 2 . The wells with antibacterial activity were analysed by LC-MS coupled to a PDA detector to identify the molecular ions of the bioactive compounds and their purity profile. The RP-HPLC profile of D. scandens species with the bioactive fractions and masses are highlighted in Fig. 1 . The microfractionation protocol facilitated the identification of target bioactive fraction/masses, which then served as a guide in the large-scale isolation of compounds. This resulted in timeefficient screening of a large number of plants for bioactivity, using very small amounts of crude extracts.
Antibacterial activity of microfractions using microdilution assay
A microdilution assay using S. aureus identified 19 of the 50 plant species (38%) as containing microfractions that exerted complete bacterial inhibition (Table 2) . Although crude aqueous extracts from 34 plant species showed activity in the microdilution assay, only 19 of these extracts gave activity after microfractionation. For example, Indigofera tinctoria, Saraca asoca, T. indica, Coccinia grandis, Hedyotis auricularia, Mitragyna parvifolia and S. hispida, lost their activity after fractionation. One possible explanation for this phenomenon is that several compounds are acting additively or in synergy in the crude extracts to give rise to the observed bioactivity. Once these are separated, each individual compound activity is below the sensitivity threshold.
Cytotoxicity of microfractions using FMCA
FMCA, using a human lymphoma cell line, was conducted to identify fractions with cytotoxic activity. Only six plant species (12%) showed any activity on this cytotoxicity assay (Table 2) . Of these, only Pavetta lanceolata showed cytotoxicity but no antibacterial activity. Similar to the microdilution assay, fractions with cytotoxic activity showed a pattern of activity with gradual increase in activity reaching a maximum, after which a gradual decrease in activity was observed. For some species, such as D. metel, O. mungos and W. somnifera, active fractions in this assay were also antibacterial, indicating the presence of broadly biocidal agents. In contrast, B. racemosa and C. alata exhibited both activities but deriving from separate regions in the chromatogram, consequently having different bioactive masses. This indicated more target specific compounds within the same plant, mediating either cytotoxicity or antibacterial activity. Antibacterial and cytotoxicity data for all species are shown in Table 2 .
Comparison of traditional use of plants with antibacterial and cytotoxic activities
The 50 plants that were screened in the current study are in most cases used in traditional medicine for conditions that are associated with microbial infections, parasitic diseases or tumours. Thus, antibacterial activity and cytotoxicity were likely two of the key biological activities mediated by the active constituents in these plants. The complete list of traditional uses of the plants screened herein, together with previous studies on their biological activities, is given in Table 1 .
Crude aqueous extracts of C. fistula, W. bicupidata and W. somnifera gave very high antibacterial activity in our bioassays. Of these, the latter plant species also gave high cytotoxicity. These plants are used in traditional medicine for treatment of conditions including fever, diarrhoea, cough, worm infestations and skin diseases where the main biological activities utilised are most likely antibacterial or cytotoxic activities.
Cytotoxicity and antibacterial activity at very low concentrations were confirmed for D. metel in our bioassays. Traditionally, D. metel is used for a variety of conditions including tuberculosis, tumours, eye diseases and worm infestations including filariasis. As given in Table 2 , the crude organic extracts of A. pavonina, C. retusa, T. indica, O. herbacea, P. foetida, S. melongena and S. virginianum showed low MIC values against tested bacteria but no cytotoxicity. Thus, our findings lend support to the traditional use of these plants. For example, urethritis is treated with P. foetida. C. retusa is used in the treatment of diarrhoea and skin diseases. Markedly, eye diseases and oral diseases are traditionally treated by T. indica. Furthermore, traditional medicinal uses of S. virginianum include treatment of cough, fever, toothache, gonorrhoea, vaginal candidiasis, worm infestations, and tuberculosis.
The plants that showed high cytotoxicity in our bioassays, D. metel and O. mungos, are traditionally used against tumours and cancer. In addition, skin infections are traditionally treated by plant extracts of W. somnifera, B. racemosa and C. alata, which also gave high cytotoxicity in FMCA.
D. scandens extract did not exhibit cell line cytotoxic activity in the FMCA despite previous reported activity using other cells and methods (Kuljittichanok et al., 2018) . However, it showed substantial antibacterial activity in the microdilution assay, which prompted large scale metabolite isolation as described below. Noteworthy is that D. scandens is a plant with extensive traditional use for treatment of wounds and stomach infections.
Isolation and structure elucidation of biologically active secondary metabolites from D. scandens
Microfractionated aliquots were subjected to antibacterial assay and the fractions with antibacterial activity were further analysed on LC-MS. The target antibacterial compounds, (+)LRESIMS at m/z (M + H) + for D. scandens were identified at 16 min (m/z 463.10), 17 min (565.07, 595.16), 18 min, (565.07) and at 19 min (611.14) as major masses (Table 2) . Interestingly, the aqueous fraction of D. scandens showed no cytotoxic activity against the lymphoma cell line. Large-scale sequential extraction with solvents of increasing polarity resulted in four fractions, with the EtOAc fraction showing significant antibacterial activity in agar disc diffusion assay (active radius was greater than 10 mm). The EtOAc fraction was partitioned with water to yield 2.1 g of crude aqueous extract. MS analysis of the crude aqueous extract partitioned from EtOAc confirmed the presence of target bioactive compounds at m/z 463.08, 565.14, 595.14 and 611.15 (M + H) + . The aqueous extract was subjected to preparative RP-HPLC and fractions containing the desired masses were pooled and re-purified by semi-preparative RP-HPLC. Isolated compounds with > 95% UV purity by analytical RP-HPLC were subjected to further bioassays and structure elucidation. The four isolated compounds through the microfractionation protocol are shown in Fig. 2. A compound (3 mg) with a HREIMS at m/z 463.1004 (M + H) + , consistent with the molecular formula of C 22 H 22 O 11 was confirmed as dalpanitin. 2D NMR data in CD 3 OD were analysed to elucidate its structure. Insufficient NMR data were reported from the previous published article due to lack of 13 C and 2D NMR data (Adinarayana and Rajasekhara Rao, 1972) ; here, the full spectroscopic data are summarised in Table 3 . This is the first time that dalpanitin is reported from D. scandens. Previously, in the early 1970s, dalpanitin was isolated from another member of Fabaceae, Dalbergia paniculata (Adinarayana and Rajasekhara Rao, 1972) . Furthermore, dalpanitin has been reported in recent times from Dalbergia velutina (Kaennakam et al., 2016) .
Rutin (2.5 mg) was identified by (+)HRESIMS analysis and comparison of 1D NMR spectroscopic data to literature values (Lin et al., 2016; Zhang et al., 2010) . Our study is the first report of rutin from D. scandens. Rutin is found in many plants, and recently it was reported from Physalis peruviana (Toro et al., 2014) . The antioxidant activity of rutin is capable of reducing capillary fragility, swelling and bruising, venous insufficiency, and for improving micro-vascular blood flow (Fathiazad et al., 2006) .
Vicenin-3 (2 mg) and vicenin-2 (2.5 mg) were obtained from largescale fractionation. The (+)HREIMS at m/z 565.1442 for [M+H] + of vicenin-3 was consistent with a molecular formula of C 26 H 28 O 14 . Vicenin-2 with a molecular formula of C 27 H 30 O 15 was confirmed by (+)HREIMS at m/z 595.1668 for its [M+H] + . The 13 C and 1 H NMR data obtained in the present study for vicenin-2 was compared with already reported data in the literature (Velozo et al., 2009) .
A retention time of 10.9 min for vicenin-2 and 11.0 min for vicenin-3 on RP-HPLC were indicative that vicenin-2 was more polar than vicenin-3. When compared to vicenin-2, the NMR data of vicenin-3 showed the loss of an oxymethine at δC 81.5, δH 3.56 (C-5′′) while the methylene resonance at δC 60.6, δH 3.89/3.66 (C-6′′) had shifted to δC 81.5, δH 3.54/3.48. This data, combined with the loss of 30 amu, indicated that vicenin-3 contained an identical structure to vicenin-2 with the exception of a D-xylopyranose moiety at C-8.
Fig. 2. Compounds isolated through microfractionation protocol, dalpanitin
(1), rutin (2), vicenin-3 (3), and vicenin-2 (4).
Minimum inhibitory concentration (MIC) determination of isolated compounds
The isolated pure compounds were tested against S. aureus, P. aeruginosa, E. coli and C. albicans in the range of 188 μg mL -1 to 1.46 μg mL -1 using 2-fold serial dilutions. Dalpanitin and vicenin-3 showed the lowest MIC value of 23 μg mL -1 against S. aureus. Furthermore, dalpanitin and vicenin-3 also showed moderate activity of 94 μg mL -1 and 188 μg mL -1 respectively against E. coli. Notably, only dalpanitin showed activity against P. aeruginosa at 94 μg mL -1 . Interestingly, none of the tested compounds showed activity against C. albicans. Gentamicin (1.46 μg mL -1 ) was used as a positive control. MIC values are given in Table 4 . The MIC of 23 μg mL -1 identified for dalpanitin and vicenin-3 are in the low and intermediary range of the clinical and laboratory standards institute (CLSI) guidelines for antibiotic potency (4-32 μg mL -1 ) (CLSI, 2015 (CLSI, , 2008 .
Although we identified several bioactive plants in addition to D. scandens from our current screen, we could not progress to large-scale isolation due the limited access to those plant materials. Nevertheless we offer that our study has highlighted several Sri Lankan plants used in traditional medicine as promising candidates for further antibiotic drug discovery studies.
Conclusion
The lack of scientific evidence for efficacy is a major concern for further development of plant-based traditional medicines. As an attempt to investigate the scientific basis of plants used in Sri Lankan traditional medicine, we conducted a bioactivity screen of 50 plant species, leading to identification of microfractions of 19 plants with antibacterial activity (i.e. fractions which inhibited growth of S. aureus) and 6 plants with cytotoxic activity where cell viability was ≤30%. Notably, a high percentage of plants that were screened in the current study were found to contain antibacterial and cytotoxic compounds. In most cases, we were able to correlate the traditional use with the confirmed antibacterial or cytotoxic activity, providing scientific support for the anecdotal evidence.
Microfractionation of the extracts was valuable to identify the bioactive metabolites in the plant extracts, which then served as a guiding tool to streamline the downstream processes for identification and large scale isolation of bioactive compounds. Notably, the microfractionation protocol is advantageous as it requires only a small amount of plant material (2 mg). The method allowed rapid screening of a large number of samples at a time and only required the collection of plant material in large scale once a target bioactive compound/mass was identified. We exemplified this by large-scale isolation of bioactive flavonoids from D. scandens, guided by molecular ions associated with bioactive fractions identified during microfractionation. In the present study, vicenin-3 and dalpanitin showed highest activity (23 μg mL -1 ) against S. aureus but showed no cytotoxicity against lymphoma cells. Follow up studies aimed at identifying the underlying mechanism of action will facilitate the design of modified pharmacophores with improved antibacterial activity.
To our knowledge, this is the first large-scale bioactivity screening effort conducted on Sri Lankan flora. As such it is a first step toward providing scientific evidence for plant-based medicines used traditionally in the region. The high in vitro hit rate for antibacterial and anticancer activity we report among the herbal extracts within the Sri Lankan flora not only enhances the confidence in the traditional Sri Lankan medicinal system but emphasises the value of the prescreening approach for ethno-pharmacologically used plants in search of putative bioactive compounds in plants. 
Table 4
Antimicrobial activity of isolated flavonoid compounds. Range of tested concentration between 1.46 μg mL -1 to 188 μg mL -1 . S. Mohotti, et al. Journal of Ethnopharmacology 246 (2020) 112158 
